for the following products
N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide | Vemurafenib and PLX4032
Established in 2009, ZHIWE is a leading company focusing on Active Pharmaceutical Ingredients (API) and intermediates.
ZHIWE built R&D center in Shanghai as well as manufacturing facilities in Hebei province. The R&D center has equipped with advanced instruments and machines, including high-pressure tank、 Ozone, HPLC and GC etc. APIchemTM can offer products ranging from milligram level, kilogram level, up to bulk tons.
Our clients widely spread from Europe, North America, and A...
